CBD Helps Bone Healing While Chronic THC Use Nearly Quadruples Spinal Fusion Failure Risk
CB2 activation and CBD promote bone repair, while chronic high-dose THC was associated with 1.8-3.6x higher spinal fusion failure.
Quick Facts
What This Study Found
CB2 agonists uniformly osteogenic. CBD accelerated early fusion. Chronic THC: 6-10% lower BMD, 1.8-3.6x higher pseudarthrosis risk. Short-course THC appeared neutral.
Key Numbers
CBD accelerated fusion. THC: 6-10% lower BMD; 1.8-3.6x higher failure. Short-course THC neutral.
How They Did This
Systematic review of three databases on cannabinoids and bone outcomes through May 2025.
Why This Research Matters
Directly actionable for millions of surgical patients: CBD helps, chronic THC harms bone healing.
The Bigger Picture
Chronic THC use is a modifiable surgical risk factor. The CB2 vs CB1 distinction is key.
What This Study Doesn't Tell Us
No prospective dosing trials. Most data preclinical.
Questions This Raises
- ?Should surgeons recommend CBD and restrict THC?
- ?What THC dose threshold is harmful?
Trust & Context
- Key Stat:
- Evidence Grade:
- Systematic review integrating preclinical and clinical evidence.
- Study Age:
- 2025 systematic review of cannabinoids and bone healing.
- Original Title:
- The Cannabinoid Pharmacology of Bone Healing: Developments in Fusion Medicine.
- Published In:
- Biomedicines, 13(8) (2025)
- Authors:
- Urreola, Gabriel, Le, Michael, Harris, Alan, Castillo, Jose A, Saiz, Augustine M, Shahzad, Hania, Martin, Allan R, Kim, Kee D, Khan, Safdar, Price, Richard
- Database ID:
- RTHC-07841
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
Does cannabis affect bone healing?
CBD promotes repair; chronic THC linked to 1.8-3.6x higher fusion failure.
Should I stop THC before surgery?
Chronic high-dose THC is a modifiable risk factor. Safe thresholds not established.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07841APA
Urreola, Gabriel; Le, Michael; Harris, Alan; Castillo, Jose A; Saiz, Augustine M; Shahzad, Hania; Martin, Allan R; Kim, Kee D; Khan, Safdar; Price, Richard. (2025). The Cannabinoid Pharmacology of Bone Healing: Developments in Fusion Medicine.. Biomedicines, 13(8). https://doi.org/10.3390/biomedicines13081891
MLA
Urreola, Gabriel, et al. "The Cannabinoid Pharmacology of Bone Healing: Developments in Fusion Medicine.." Biomedicines, 2025. https://doi.org/10.3390/biomedicines13081891
RethinkTHC
RethinkTHC Research Database. "The Cannabinoid Pharmacology of Bone Healing: Developments i..." RTHC-07841. Retrieved from https://rethinkthc.com/research/urreola-2025-the-cannabinoid-pharmacology-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.